Reselute 股骨远端钢板
K号: K253517 · 2026-03-10
广告
决定日期2026-03-10
产品代码HSB
咨询委员会OR
请注意，由于原文中未提供具体的医疗设备监管文本，以下是一个示例翻译，您可以根据实际文本进行调整：
---
产品名称：[产品名称]
公司名称：[公司名称]
根据FDA 510(k)预市场批准程序，[产品名称]已获得批准，用于[产品用途描述]。
产品注册号：[注册号]
PMA编号：[PMA编号]
临床试验编号（NCT）：[NCT编号]
PubMed ID（PMID）：[PMID编号]
更多信息请访问以下链接：
[URL]
---
请将上述示例中的[产品名称]、[公司名称]、[注册号]、[PMA编号]、[NCT编号]、[PMID编号]和[URL]替换为实际的文本内容。
决定实质等同
器械摘要
Reselute Tibial Nail is the device name listed in this FDA 510(k) record. The listed applicant is Reselute, Inc.. It received FDA 510(k) clearance on 2026-03-10 under 510(k) number K253517. The device is classified under product code HSB. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.
常见问题
What is the Reselute Tibial Nail?
Reselute Tibial Nail is a medical device that received FDA 510(k) clearance on 2026-03-10. The listed applicant is Reselute, Inc.. The 510(k) number is K253517.
When did Reselute Tibial Nail receive FDA 510(k) clearance?
Reselute Tibial Nail received FDA 510(k) clearance on 2026-03-10, under 510(k) number K253517.
Who is the listed applicant for Reselute Tibial Nail?
The FDA 510(k) record lists Reselute, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Reselute Tibial Nail?
The FDA product code for Reselute Tibial Nail is HSB.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
相关器械（代码：HSB）
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
K261345儿童接骨平台 股骨OrthoPediatrics Corp.K261481Pangea股骨重建系统Stryker GmbHK253080AND 医疗股骨钉系统（PFNA01）；AND 医疗股骨钉系统（PFNA02）Suzhou and Science & Technology Development Corp.K261651Precice® Max System and Precice® Ankle Salvage SystemNuVasive Specialized OrthopedicsK253155富乐金属锁定髓内钉系统Beijing Fule Science & Technology Development Co., Ltd.K253046HERA 齿锁髓内钉系统ZheJiang Decans Medical Devices Co., Ltd.
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告